ES2105986A1 - Utilizacion de los derivados de 2-(4-(azolilbutil)(metil)) bencimidazol y analogos, asi como de sus sales, para la preparacion de medicamentos destinados al tratamiento o a la profilaxis del asma. - Google Patents

Utilizacion de los derivados de 2-(4-(azolilbutil)(metil)) bencimidazol y analogos, asi como de sus sales, para la preparacion de medicamentos destinados al tratamiento o a la profilaxis del asma.

Info

Publication number
ES2105986A1
ES2105986A1 ES09502465A ES9502465A ES2105986A1 ES 2105986 A1 ES2105986 A1 ES 2105986A1 ES 09502465 A ES09502465 A ES 09502465A ES 9502465 A ES9502465 A ES 9502465A ES 2105986 A1 ES2105986 A1 ES 2105986A1
Authority
ES
Spain
Prior art keywords
azolylbutyl
piperazinyl
methyl
treating
benzimidazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09502465A
Other languages
English (en)
Other versions
ES2105986B1 (es
Inventor
Altisent Maria Rosa Cuberes
Constansa Jordi Frigola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of ES2105986A1 publication Critical patent/ES2105986A1/es
Application granted granted Critical
Publication of ES2105986B1 publication Critical patent/ES2105986B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UTILIZACION DE LOS DERIVADOS DE 2-[4-(AZOLILBUTIL) PIPERACINIL (METIL)] BENCIMIDAZOL Y ANALOGOS, ASI COMO DE SUS SALES, PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS AL TRATAMIENTO O A LA PROXILASIS DEL ASMA. LA INVENCION SE REFIERE A LA UTILIZACION DE LOS DERIVADOS DE 2-[4-(AZOLILBUTIL) PIPERACINIL (METIL)] BENCIMIDAZOL Y ANALOGOS, ASI COMO DE SUS SALES, PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS AL TRATAMIENTO O A LA PROXILASIS DEL ASMA EN LOS MAMIFEROS, INCLUIDO EL HOMBRE.
ES09502465A 1994-12-08 1995-12-07 Utilizacion de los derivados de 2-(4-(azolilbutil) piperacinil (metil)bencimidazol y analaagos, asi como de sus sales, para la preparacion de medicamentos destinados al tratamiento o a la profilaxis del asma. Expired - Lifetime ES2105986B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9414766A FR2727865B1 (fr) 1994-12-08 1994-12-08 Utilisation des derives de 2-(4-(azolybutyl)-piperazinyl- (methyl))-benzimidazole et analogues ainsi que de leurs sels, pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme

Publications (2)

Publication Number Publication Date
ES2105986A1 true ES2105986A1 (es) 1997-10-16
ES2105986B1 ES2105986B1 (es) 1998-07-01

Family

ID=9469596

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09502465A Expired - Lifetime ES2105986B1 (es) 1994-12-08 1995-12-07 Utilizacion de los derivados de 2-(4-(azolilbutil) piperacinil (metil)bencimidazol y analaagos, asi como de sus sales, para la preparacion de medicamentos destinados al tratamiento o a la profilaxis del asma.

Country Status (9)

Country Link
EP (1) EP0741571A1 (es)
JP (1) JPH09508923A (es)
AU (1) AU714581B2 (es)
BR (1) BR1100852A (es)
CA (1) CA2182904A1 (es)
ES (1) ES2105986B1 (es)
FR (1) FR2727865B1 (es)
WO (1) WO1996017609A1 (es)
ZA (1) ZA9510435B (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0440811A1 (en) * 1989-08-28 1991-08-14 Kanebo, Ltd. Composition for percutaneous administration
EP0468884A1 (fr) * 1990-07-26 1992-01-29 Laboratorios Del Dr. Esteve, S.A. Nouveaux dérivés de benzimidazole, leur préparation, et leur application en tant que médicaments
EP0507696A1 (fr) * 1991-04-05 1992-10-07 Laboratorios Del Dr. Esteve, S.A. Antihistaminiques non sédatifs, dérivés de benzimidazole, leur procédé de préparation et leur utilisation en tant que médicaments.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
FR2668150B1 (fr) * 1990-10-17 1994-11-18 Theramex Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0440811A1 (en) * 1989-08-28 1991-08-14 Kanebo, Ltd. Composition for percutaneous administration
EP0468884A1 (fr) * 1990-07-26 1992-01-29 Laboratorios Del Dr. Esteve, S.A. Nouveaux dérivés de benzimidazole, leur préparation, et leur application en tant que médicaments
EP0507696A1 (fr) * 1991-04-05 1992-10-07 Laboratorios Del Dr. Esteve, S.A. Antihistaminiques non sédatifs, dérivés de benzimidazole, leur procédé de préparation et leur utilisation en tant que médicaments.

Also Published As

Publication number Publication date
EP0741571A1 (fr) 1996-11-13
AU714581B2 (en) 2000-01-06
JPH09508923A (ja) 1997-09-09
ES2105986B1 (es) 1998-07-01
AU4261196A (en) 1996-06-26
FR2727865B1 (fr) 1997-07-18
BR1100852A (pt) 1999-10-13
WO1996017609A1 (fr) 1996-06-13
ZA9510435B (en) 1996-06-14
CA2182904A1 (fr) 1996-06-13
FR2727865A1 (fr) 1996-06-14

Similar Documents

Publication Publication Date Title
DE69726245D1 (de) Befeuchtungsgerät zur Behandlung von Atemstillstand im Schlaf
DK0907365T3 (da) Hidtil ukendt formulering
NO934630L (no) Antiallergisk sammensetning for oftalmisk eller masal anvendelse
SI0955295T1 (en) Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl) piperazines
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
NO870241L (no) Hypoglykemiske tiazolidindioner.
SE9401728D0 (sv) New compounds II
DE69106237T2 (de) Antimigräne Alkoxypyrimidinderivate.
WO1993000094A3 (en) Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
PT790236E (pt) Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
DK0442423T3 (da) Anvendelse af buspiron ved søvnapnøer
ES2105986A1 (es) Utilizacion de los derivados de 2-(4-(azolilbutil)(metil)) bencimidazol y analogos, asi como de sus sales, para la preparacion de medicamentos destinados al tratamiento o a la profilaxis del asma.
NZ336804A (en) Use of pramipexole in the treatment of restless legs syndrome
FR2660862B1 (fr) Application therapeutique de derives de l'histamine, nouveau derive de l'histamine et utilisation de ces derives pour la preparation de medicaments.
AU5403099A (en) Method for controlling the use of furniture to sit or lie on, put at users' disposal and piece of furniture used therewith
ITMI911315A0 (it) Corpo di cuscino e procedimento per la formazione del medesimo
NO983829L (no) Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer
SE9602262D0 (sv) New use of derivatives of cystine
NO167390C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonylderivater.
NZ301453A (en) 4-(substituted phenyl),4-(substituted carboxyl, carboxylamide or alkyl)-cyclohexan-1-one derivatives and medicaments
AU7358896A (en) 1-{4-(4'-sulfanilyl)phenyl}urea and derivatives for the treatment of leishmaniasis
FI973631A (fi) 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö
IT9041649A0 (it) Protettore della cornea e metodo per il suo ottenimento.
ES2149691A1 (es) 2-4-[4-(4,5-dicloro-2metilimidazol-1-il)butil]-1-piperacinil -5-fluoropirimidina, su preparacion y su utilizacion terapeutica.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971016

Kind code of ref document: A1

Effective date: 19971016